URSOFALK ® T500 tabletas de 500 mg no debe usarse en el primer trimestre del embarazo, puesto que no se cuenta con los datos suficientes acerca del riesgo que representa para el feto. For patients weighing less than 47 kg or patients who are unable to swallow Ursofalk® 500mg film-coated tablets, Ursofalk® capsules or suspension are available. Medical information for Ursofalk including its dosage, uses, side, effects, interactions, pictures and warnings. Ursofalk 500mg film-coated tablets - Patient Information Leaflet (PIL) by Dr. Falk Pharma UK Ltd Ursofalk is a naturally occurring bile acid used to treat different hepatobilliary disorders. The activity of Ursofalk is achieved through a decrease in secretion of cholesterol in bile. Ursofalk 500mg can increase the absorption of ciclosporin from the intestine. In patients receiving ciclosporin treatment, blood concentrations of this substance should therefore be checked by physician and the ciclosporin dose adjusted if necessary. Ursofalk 500mg is a bile acid which is physiologically synthesized in the human liver and is also formed by bacteria in the large intestine. It is present in human bile making up 1.4-4% of the biliary bile acids. Ursofalk 250mg Capsule contains ursodeoxycholic acid and is mainly used to dissolve certain cholesterol gallstones and to treat liver diseases such as primary biliary cholangitis. What is URSOFALK 500 mg used for? URSOFALK 500 mg is primarily used to treat liver diseases, including primary biliary cholangitis and certain types of gallstones. Ursofalk contains ursodeoxycholic acid (UDCA), a naturally occurring bile acid used to dissolve small cholesterol gallstones and to treat primary biliary cholangitis (PBC). It is also prescribed for cystic fibrosis-associated liver disease in children aged 6 to 18 years.